See also this year's filing and all EDGAR filings for this company.
PDF Report 0001662524_2019_Akcea_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001662524, Akcea Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 267,235,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 88,914,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,696,000 |
| 3 | remainder_Assets | 3,416,000 |
| 4 | LiabilitiesCurrent | 80,661,000 |
| 5 | LiabilitiesNoncurrent | 3,434,000 |
| 6 | remainder_Liabilities | 4,442,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 153,610,000 |
| 9 | ResearchAndDevelopmentExpense | 130,340,000 |
| 10 | remainder_Expenses | 12,180,000 |
| 11 | remainder_Revenues | 64,867,000 |
| 12 | remainder_NetIncome | 5,442,000 |
| 13 | remainder_ComprehensiveNetIncome | 127,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 365,261,000 |
| 1 | Liabilities | 88,537,000 |
| 2 | Expenses | 296,130,000 |
| 3 | Revenues | 64,867,000 |
| 4 | StockholdersEquity | 276,724,000 |
| 5 | NetIncome | -225,821,000 |
| 6 | ComprehensiveNetIncome | -225,757,500 |
| 7 | BaseVar | 410,182,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.66 |
| 9 | EconomicCapitalRatio | 2.79 |
Edgar->Model Mapping
Feature Distribution
Change over Time
